Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999.
Rapaport F, Seier K, Neelamraju Y, Hassane D, Baslan T, Gildea DT, Haddox S, Lee T, Murdock HM, Sheridan C, Thurmond A, Wang L, Carroll M, Cripe LD, Fernandez H, Mason CE, Paietta E, Roboz GJ, Sun Z, Tallman MS, Zhang Y, Gönen M, Levine R, Melnick AM, Kleppe M, Garrett-Bakelman FE.
Rapaport F, et al. Among authors: gildea dt.
Blood Cancer J. 2023 Jul 6;13(1):103. doi: 10.1038/s41408-023-00862-2.
Blood Cancer J. 2023.
PMID: 37407550
Free PMC article.
No abstract available.